Evidence map›Paper›PMID 40035548›Full record

ArticleAntimicrobial agents and chemotherapy2025

Multicenter, retrospective cohort study of antimycobacterial treatment-related harms among patients with non-tuberculosis

Michael P Veve, Rachel M Kenney, Alisar M Aljundi, Michelle S Dierker, Vasilios Athans, Anita B Shallal, Nimish Patel

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael P VeveDepartment of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.ORCID 0000-0001-5967-5211
Rachel M KenneyDepartment of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.
Alisar M AljundiDepartment of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.
Michelle S DierkerDepartment of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.
Vasilios AthansDepartment of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Anita B ShallalDepartment of Infectious Diseases, Henry Ford Hospital, Detroit, Michigan, USA.
Nimish PatelSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.

Funding

Paratek Pharmaceuticals
6 · The paper itself

Abstract

Non-tuberculosis mycobacteria (NTM) are extensively drug-resistant organisms that require long-term therapy. The study purpose was to quantify the incidence of and risk factors for antimycobacterial-associated adverse drug events (ADEs) in persons with NTM infections receiving outpatient therapy. A multicenter, retrospective cohort was performed of persons with NTM infections who received antimycobacterial treatment from 2013 to 2024. Inclusion criteria were age ≥18 years, ≥1 month of outpatient treatment, and ≥1 follow-up outpatient visit within 3 months of index encounter.

Indexed as

Anti-Bacterial AgentsMycobacterium Infections, NontuberculousNontuberculous MycobacteriaAcute Kidney InjuryAdultAgedAged, 80 and overAminoglycosidesClostridium InfectionsFemaleHumansMacrolidesMaleMiddle AgedRetrospective StudiesRisk FactorsAminoglycosidesAnti-Bacterial AgentsMacrolidesadverse drug eventantimicrobial stewardshipMycobacterium abscessusnon-tuberculosis mycobacteria

Identifiers

PMID40035548
PMCPMC11963606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.